Research and Markets: World Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Therapeutics Pipeline Review, H2 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/b6qslg/metastatic) has announced the addition of the "Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

- AB Science SA

- AbbVie Inc.

- Adamis Pharmaceuticals Corporation

- Advaxis, Inc.

- Ambrx, Inc.

- Amgen Inc.

- Arrowhead Research Corporation

- AstraZeneca Plc

- ATLAB Pharma SAS

- Bavarian Nordic A/S

- BIND Therapeutics, Inc.

- Boehringer Ingelheim GmbH

- Bristol-Myers Squibb Company

- CellCentric Ltd

- CureVac GmbH

- DexTech Medical AB

- Eli Lilly and Company

- Emergent BioSolutions Inc.

- F. Hoffmann-La Roche Ltd.

- Genentech, Inc.

- GenSpera, Inc.

- GlaxoSmithKline Plc

- GTx, Inc.

- Medivation, Inc.

- NewLink Genetics Corporation

- Orion Oyj

- Pfizer Inc.

- Progenics Pharmaceuticals, Inc.

- Sanofi

- Sotio a.s.

- Sun Pharma Advanced Research Company Ltd.

- Supratek Pharma Inc.

- Taiho Pharmaceutical Co., Ltd.

- Takeda Pharmaceutical Company Limited

- Viralytics Ltd.

For more information visit http://www.researchandmarkets.com/research/b6qslg/metastatic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology